Industry Insider Activity

Drug Manufacturers - General insider activity

Concentrated executive and director transaction evidence across 11 companies, with acquisition/disposal balance, filing cadence, value concentration, and linked company research.

Latest filing 20 Jul 2026 505 filings tracked

Top-level read

Net insider buying

Drug Manufacturers - General shows 302 acquisition filings against 203 disposal filings. The largest stored filing is $26.1M in AMGN by BRADWAY, ROBERT A.

Net value $48.2Macquisitions minus disposals
Companies 11with stored filings
Total filings 505stored transaction rows
Acquisition value $105.6M302 acquisitions
Disposal value $57.4M203 disposals
Largest filing $26.1Mreported transaction value

Filing cadence

Last 12 active months
Mar 2026 118
Apr 2026 118
May 2026 162
Jun 2026 80
Jul 2026 27

Acquisitions 59.8% · Disposals 40.2%

Company Reads

Most active company insider tapes

11 shown

Transaction Evidence

Latest filings in Drug Manufacturers - General

Showing 91-120 of 505
Date 9 Jun 2026
Symbol BIIBBiogen Inc
Insider FREIRE, MARIA CDirector
Side Acquisition
Shares 2005
Value 0
Industry Drug Manufacturers - General
Date 9 Jun 2026
Symbol BIIBBiogen Inc
Insider HAWKINS, WILLIAM ADirector
Side Acquisition
Shares 1505
Value 0
Industry Drug Manufacturers - General
Date 9 Jun 2026
Symbol BIIBBiogen Inc
Insider LANGER, SUSANDirector
Side Acquisition
Shares 1505
Value 0
Industry Drug Manufacturers - General
Date 9 Jun 2026
Symbol BIIBBiogen Inc
Insider MANTAS, JESUS BDirector
Side Acquisition
Shares 1505
Value 0
Industry Drug Manufacturers - General
Date 9 Jun 2026
Symbol BIIBBiogen Inc
Insider MINOR, LLOYDDirector
Side Acquisition
Shares 1505
Value 0
Industry Drug Manufacturers - General
Date 9 Jun 2026
Symbol BIIBBiogen Inc
Insider PANGALOS, MENELAS NDirector
Side Disposal
Shares 2370
Value 0
Industry Drug Manufacturers - General
Date 9 Jun 2026
Symbol BIIBBiogen Inc
Insider PANGALOS, MENELAS NDirector
Side Acquisition
Shares 2370
Value 0
Industry Drug Manufacturers - General
Date 9 Jun 2026
Symbol BIIBBiogen Inc
Insider PANGALOS, MENELAS NDirector
Side Acquisition
Shares 1505
Value 0
Industry Drug Manufacturers - General
Date 9 Jun 2026
Symbol BIIBBiogen Inc
Insider PATOLAWALA, MONISH DDirector
Side Acquisition
Shares 1505
Value 0
Industry Drug Manufacturers - General
Date 9 Jun 2026
Symbol BIIBBiogen Inc
Insider ROWINSKY, ERIC KDirector
Side Acquisition
Shares 1505
Value 0
Industry Drug Manufacturers - General
Date 9 Jun 2026
Symbol BIIBBiogen Inc
Insider SHERWIN, STEPHEN ADirector
Side Acquisition
Shares 1505
Value 0
Industry Drug Manufacturers - General
Date 3 Jun 2026
Symbol BMYBristol-Myers Squibb Company
Insider SHORT, BARTIE WENDYEVP, Corporate Affairs
Side Disposal
Shares 3876
Value 212095
Industry Drug Manufacturers - General
Date 3 Jun 2026
Symbol BMYBristol-Myers Squibb Company
Insider SHORT, BARTIE WENDYEVP, Corporate Affairs
Side Acquisition
Shares 8040
Value 0
Industry Drug Manufacturers - General
Date 3 Jun 2026
Symbol BMYBristol-Myers Squibb Company
Insider SHORT, BARTIE WENDYEVP, Corporate Affairs
Side Disposal
Shares 8040
Value 0
Industry Drug Manufacturers - General
Date 1 Jun 2026
Symbol GILDGilead Sciences Inc
Insider O'DAY, DANIEL PATRICKDirector, Chairman & CEO
Side Disposal
Shares 10900
Value 1428983
Industry Drug Manufacturers - General
Date 1 Jun 2026
Symbol GILDGilead Sciences Inc
Insider O'DAY, DANIEL PATRICKDirector, Chairman & CEO
Side Disposal
Shares 3062
Value 404843
Industry Drug Manufacturers - General
Date 1 Jun 2026
Symbol GILDGilead Sciences Inc
Insider O'DAY, DANIEL PATRICKDirector, Chairman & CEO
Side Disposal
Shares 1038
Value 138021
Industry Drug Manufacturers - General
Date 29 May 2026
Symbol MRKMerck & Company Inc
Insider BAKER, DOUGLAS M JRDirector
Side Acquisition
Shares 1853
Value 220000
Industry Drug Manufacturers - General
Date 29 May 2026
Symbol MRKMerck & Company Inc
Insider COE, MARY ELLENDirector
Side Acquisition
Shares 1853
Value 220000
Industry Drug Manufacturers - General
Date 29 May 2026
Symbol MRKMerck & Company Inc
Insider CRAIG, PAMELA J.Director
Side Acquisition
Shares 1853
Value 220000
Industry Drug Manufacturers - General
Date 29 May 2026
Symbol MRKMerck & Company Inc
Insider GLOCER, THOMAS HDirector
Side Acquisition
Shares 1853
Value 220000
Industry Drug Manufacturers - General
Date 29 May 2026
Symbol MRKMerck & Company Inc
Insider KARSANBHAI, SURENDRALAL LANCADirector
Side Acquisition
Shares 1853
Value 220000
Industry Drug Manufacturers - General
Date 29 May 2026
Symbol MRKMerck & Company Inc
Insider LAVIZZO-MOUREY, RISA JDirector
Side Acquisition
Shares 1853
Value 220000
Industry Drug Manufacturers - General
Date 29 May 2026
Symbol MRKMerck & Company Inc
Insider MAYO, STEPHENDirector
Side Acquisition
Shares 1853
Value 220000
Industry Drug Manufacturers - General
Date 29 May 2026
Symbol MRKMerck & Company Inc
Insider ROTHMAN, PAULDirector
Side Acquisition
Shares 1853
Value 220000
Industry Drug Manufacturers - General
Date 29 May 2026
Symbol MRKMerck & Company Inc
Insider RUSSO, PATRICIA FDirector
Side Acquisition
Shares 1853
Value 220000
Industry Drug Manufacturers - General
Date 29 May 2026
Symbol MRKMerck & Company Inc
Insider SEIDMAN, CHRISTINE EDirector
Side Acquisition
Shares 1853
Value 220000
Industry Drug Manufacturers - General
Date 29 May 2026
Symbol MRKMerck & Company Inc
Insider THULIN, INGE GDirector
Side Acquisition
Shares 1853
Value 220000
Industry Drug Manufacturers - General
Date 29 May 2026
Symbol MRKMerck & Company Inc
Insider WARDEN, KATHY JDirector
Side Acquisition
Shares 1853
Value 220000
Industry Drug Manufacturers - General
Date 29 May 2026
Symbol PFEPfizer Inc
Insider BOURLA, ALBERTDirector, Chairman & CEO
Side Acquisition
Shares 23
Value 602
Industry Drug Manufacturers - General